These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Current status of stem cell therapy for liver diseases. Souza BS; Nogueira RC; de Oliveira SA; de Freitas LA; Lyra LG; Ribeiro dos Santos R; Lyra AC; Soares MB Cell Transplant; 2009; 18(12):1261-79. PubMed ID: 19660179 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte transplantation: development of new systems for liver repopulation and gene therapy. Gupta S; Wilson JM; Chowdhury JR Semin Liver Dis; 1992 Aug; 12(3):321-31. PubMed ID: 1439883 [TBL] [Abstract][Full Text] [Related]
11. Stem cells as a treatment for chronic liver disease and diabetes. Levicar N; Dimarakis I; Flores C; Tracey J; Gordon MY; Habib NA Handb Exp Pharmacol; 2007; (180):243-62. PubMed ID: 17554512 [TBL] [Abstract][Full Text] [Related]
12. Foreword: prospects of liver cell transplantation and liver-directed gene therapy. Chowdhury JR Semin Liver Dis; 1999; 19(1):1-6. PubMed ID: 10349678 [TBL] [Abstract][Full Text] [Related]
13. Cell-delivery therapeutics for liver regeneration. Zhang W; Tucker-Kellogg L; Narmada BC; Venkatraman L; Chang S; Lu Y; Tan N; White JK; Jia R; Bhowmick SS; Shen S; Dewey CF; Yu H Adv Drug Deliv Rev; 2010 Jun; 62(7-8):814-26. PubMed ID: 20193722 [TBL] [Abstract][Full Text] [Related]
15. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Resnick IB; Shapira MY; Slavin S Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565 [TBL] [Abstract][Full Text] [Related]
16. Advances in cell therapy for renal failure. Humes HD; Szczypka MS Transpl Immunol; 2004 Apr; 12(3-4):219-27. PubMed ID: 15157916 [TBL] [Abstract][Full Text] [Related]
17. Human hepatocyte transplantation: state of the art. Fitzpatrick E; Mitry RR; Dhawan A J Intern Med; 2009 Oct; 266(4):339-57. PubMed ID: 19765179 [TBL] [Abstract][Full Text] [Related]
18. [Current status of cell-based therapies in liver diseases]. Petersen J; Ott M; von Weizsäcker F Z Gastroenterol; 2001 Nov; 39(11):975-80. PubMed ID: 11778158 [TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R Clin Transpl; 2003; ():275-82. PubMed ID: 15387119 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice. Song S; Witek RP; Lu Y; Choi YK; Zheng D; Jorgensen M; Li C; Flotte TR; Petersen BE Hepatology; 2004 Oct; 40(4):918-24. PubMed ID: 15382177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]